HyperBio Therapeutics ApS
CVR 41244909 · Private limited company (ApS) · Dissolved after voluntary liquidation
HyperBio Therapeutics ApS is a Private limited company (ApS), founded on , based in Vejle Øst. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is no longer active (status: dissolved after voluntary liquidation). 4 annual reports have been published. The latest annual report (31 Dec 2023) shows equity of DKK 740k and a net result of DKK -973k.
Company details
- CVR number
- 41244909
- Status
- Dissolved after voluntary liquidation
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- c/o Ursus Law Firm, Stærmosevej 12
7120 Vejle Øst - Municipality
- Vejle
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 48k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 5.0% |
| Current ratio | 105% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2023 | 2022 |
|---|---|---|
| Gross profit | DKK -74k | DKK -8.6m |
| Net profit | DKK -973k | DKK -7.7m |
| Equity | DKK 740k | DKK -2.3m |
| Total assets | DKK 14.7m | DKK 15.7m |
| Cash | DKK 14.4m | – |
| Short-term debt | DKK 13.9m | – |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2023 – 31 Dec 2023 | 169 | ||
| 1 Jan 2022 – 31 Dec 2022 | 164 | ||
| 1 Jan 2021 – 31 Dec 2021 | 150 | ||
| 12 Mar 2020 – 31 Dec 2020 | 130 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Søren Sylvester Skjærbæk | ||
| Board | Morten Døssing | ||
| Board | Niccolo' Bacchi-Bønnelykke | ||
| Owner (100%) | Novo Holdings A/S | ||
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | ||
| Founder | Novo Holdings A/S |
The CEOs' other companies
Søren Sylvester Skjærbæk – 12 other companies, of which 1 bankrupt
- LEDBANNER A/S Bankrupt 16 Sep 2010
- ACTAS A/S Active
- Akylox Therapeutics ApS Active
- BIOMEDICOS A/S Compulsorily dissolved
- JOMS ApS Active
- Life Science Legal ApS Active
- NSEXPLORER A/S Opløst
- NSGENE A/S Opløst
- Orbis Medicines ApS Active
- RheumaLogics ApS Active
- SOJA ApS Opløst
- UNIKUM Therapeutics ApS Active
Address history (0 moves)
| c/o Ursus Law Firm, Stærmosevej 12, 7120 Vejle Øst |
Other companies at the same address
- JOMS ApS Active
- Life Science Legal ApS Active
Similar companies in Vejle
- LIPLASOME PHARMA ApS Vejle
Questions and answers about HyperBio Therapeutics ApS
Has HyperBio Therapeutics ApS gone bankrupt?
No, HyperBio Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.
When was HyperBio Therapeutics ApS founded?
HyperBio Therapeutics ApS was founded on 12 March 2020.
What is the equity of HyperBio Therapeutics ApS?
Equity was DKK 740k according to the annual report for the period ending 31 December 2023.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.